Evidence guide
How do RPM and CCM work together in a managed care team?
Vironix combines RPM and CCM to connect information gathered between visits with ongoing care management. The pathway links readings with outreach, adherence support, care-plan follow-up and coordination. Studies labeled RPM vary in these activities, so their findings should be interpreted in the context of the care actually delivered.
Summary by Vironix Health · Source review: November 12, 2026
How we select and interpret evidence
Curation cutoff: November 12, 2026
What to take away
- In the blood-pressure and heart-failure studies, monitoring was paired with review, outreach and treatment: the functions a combined RPM+CCM service brings together.
- Ask what care accompanied the monitoring; an RPM label alone does not describe the complete intervention.
- A managed team can carry out agreed operational work while coordinating clinical follow-up with the practice.
Why connect RPM with CCM?
Monitoring supplies information between visits. Continuing care management can help connect that information with patient outreach, adherence support, care-plan follow-up and coordination. These are the functions Vironix brings together in its combined model; the service agreement defines their scope and the practice’s responsibilities.
Thomas’s realist review describes how patient selection, timely response and coordination may contribute to a monitoring pathway. It helps explain the rationale for connected care, but it is not a randomized comparison of RPM+CCM with RPM alone. A rationale for combining services should be distinguished from proof of an additional treatment effect.
Supporting studies: Emma E Thomas (2021) [1]
What care accompanied monitoring in the cited studies?
These examples distinguish reported care from a formal test of combined enrollment. “Not reported” means the source does not establish whether an activity occurred; it should not be read as “not provided.”
Study | Care reported alongside monitoring | What the comparison can establish |
|---|---|---|
Home BP guided medication treatment; self-management support varied and was optional. | Not a direct RPM+CCM comparison. Monitoring without BP-guided medication treatment was excluded. | |
Measurement, digital feedback, clinician-directed medication adjustment and self-management support. | A supported treatment package versus usual care; not a trial of formal Medicare CCM. | |
Communication, education and self-management support varied between programs. | Component comparisons are exploratory; they do not isolate adding formal CCM. | |
Daily weight and symptom monitoring plus education. | A neutral primary result despite a supported pathway; missing CCM is not an established explanation. |
Supporting studies: Sameer Acharya (2024) [2]; Richard J McManus (2021) [3]; Ignace L J De Lathauwer (2025) [4]; Michel Galinier (2020) [5]
Coordinate the practice and managed care team
This checklist is our implementation interpretation of the workflow evidence. It describes activities to coordinate with a service partner, rather than a list of functions the practice must build or staff itself. The division of work depends on the agreed service model.
Part of the pathway | Service support to agree | Coordination with the practice |
|---|---|---|
Enrollment and patient support | Patient education, device onboarding and follow-up for missing readings. | Confirm suitable patients and share relevant care-plan and access needs. |
Routine monitoring | Review incoming readings, conduct outreach and document activity. | Agree review coverage and when the treating team should be involved. |
Clinical follow-up | Route concerns through the agreed care pathway and track follow-up. | Identify clinical decision-makers, escalation contacts and how completion is confirmed. |
Access and coverage | Explain access to digital tools, staffed monitoring hours and after-hours pathways. | Align patient instructions with the practice’s urgent-care arrangements. |
Documentation and evaluation | Prepare activity reports and summarize patient and program trends. | Agree reporting needs, review results together and clarify any practice-side follow-up. |
Supporting studies: Emma E Thomas (2021) [1]; Luiza Palmieri Serrano (2023) [6]
Connect review to treatment and support
The hypertension and heart-failure reviews describe multicomponent care. Medication management, education and communication occur together in many programs. Those activities are relevant to designing combined RPM+CCM, but they should not be relabeled as formal CCM unless the source identifies that program.
A study evaluating fewer activities does not test the whole combined service. Equally, a favorable supported-monitoring result does not isolate the effect of adding CCM, and a neutral result should not be attributed to missing CCM without evidence. Compare the intervention and usual care before judging whether the finding applies.
Supporting studies: Sameer Acharya (2024) [2]; Ignace L J De Lathauwer (2025) [4]
Design support around the care team
Serrano reports practitioner experiences, while Sina describes variable follow-up use after virtual visits. These findings can inform how a managed team supports review, communication and follow-up; they do not quantify the workload of a particular service. Ravi’s diabetes synthesis pooled overlapping reviews without removing duplicate primary studies, so its narrow interval may overstate precision. These sources inform design and evaluation questions rather than a universal staffing model.
Supporting studies: Luiza Palmieri Serrano (2023) [6]; Maryam Sina (2025) [7]; Sumathy Ravi (2025) [8]
Tailor the pathway to the condition
Nagase’s COPD review rated the evidence low or very low certainty, too uncertain to show consistent gains in quality of life or utilization, so COPD programs need defined goals and local measurement. Sparse adverse-event reporting also prevents an unqualified safety claim. A pathway supported in hypertension or heart failure must still be evaluated in its intended population.
Vironix’s COPD work began with a peer-reviewed machine-learning approach to triaging patients with COPD (PLoS One, 2017). See Vironix science and publications.
Supporting studies: Fernanda Inagaki Nagase (2022) [9]
Match the virtual visit to the clinical task
Agarwal maps primary-care uses but does not establish effectiveness through formal quality appraisal. Hatef’s pandemic comparisons have substantial bias and historical-comparator confounding. Caffery’s video-versus-phone findings vary by task; reports of similar results do not automatically establish equivalence.
Supporting studies: Payal Agarwal (2025) [10]; Elham Hatef (2024) [11]; Liam J Caffery (2025) [12]
Plan for access barriers and safety follow-up
Wennberg identifies lower video use among adults facing language barriers, with high confounding risk. Preserve workable access options and evaluate who is being missed. The AHRQ safety review found sparse harms data and no eligible evaluations of specific safety practices; it does not prove all video care is safe. Define how missed follow-up, diagnostic uncertainty and urgent escalation are handled.
Supporting studies: Erica Wennberg (2025) [13]; Michael Rosen (2023) [14]
Evidence gaps
Much of the component evidence is explanatory, qualitative or exploratory. The reviews do not establish a universal staffing model, alert threshold or response time. Publication date can be much later than the underlying search cutoff.
Practical interpretation
Evaluate the full RPM+CCM pathway: what is measured, what care follows, and whether follow-up reaches completion. The clinical rationale is to connect monitoring with continuing support; the size of any additional benefit must be established by suitable comparative evidence.
A managed service can bring together onboarding, monitoring, patient engagement and documentation so the practice does not have to build every function itself. Use the evidence to discuss how that support fits your patients and connects with your clinical team.
These publications cover varied care models. They do not evaluate Vironix’s staffing, service commitments or commercial terms. Those arrangements are defined through the service model agreed with each practice.
Use the blood-pressure guide, heart-failure guide and CCM guide to identify relevant patient outcomes. The economic evidence guide explains how delivery models affect the interpretation of costs.
Explore Vironix RPM services and CCM services, or discuss your practice’s requirements to see how the managed team can support your program.
References
- Factors influencing the effectiveness of remote patient monitoring interventions: a realist review
Emma E Thomas; Monica L Taylor; Annie Banbury; Centaine L Snoswell; Helen M Haydon; Victor M Gallegos Rejas; Anthony C Smith; Liam J Caffery. BMJ Open. 2021.
Original source - Self-Measured Blood Pressure-Guided Pharmacotherapy: A Systematic Review and Meta-Analysis of United States-Based Telemedicine Trials
Sameer Acharya; Gagan Neupane; Austin Seals; Madhav Kc; Dean Giustini; Sharan Sharma; Yhenneko J Taylor; Deepak Palakshappa; Jeff D Williamson; Justin B Moore; Hayden B Bosworth; Yashashwi Pokharel. Hypertension. 2024.
Original source - Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial
Richard J McManus; Paul Little; Beth Stuart; Katherine Morton; James Raftery; Jo Kelly; Katherine Bradbury; Jin Zhang; Shihua Zhu; Elizabeth Murray; Carl R May; Frances S Mair; Susan Michie; Peter Smith; Rebecca Band; Emma Ogburn; Julie Allen; Cathy Rice; Jacqui Nuttall; Bryan Williams; Lucy Yardley; HOME BP investigators. The BMJ. 2021.
Original source - Remote patient monitoring in heart failure: A comprehensive meta-analysis of effective programme components for hospitalization and mortality reduction
Ignace L J De Lathauwer; Wessel W Nieuwenhuys; Frederique Hafkamp; Marta Regis; Rutger W M Brouwers; Mathias Funk; Hareld M C Kemps. European Journal of Heart Failure. 2025.
Original source - Telemonitoring versus standard care in heart failure: a randomised multicentre trial
Michel Galinier; François Roubille; Philippe Berdague; Gilles Brierre; Philippe Cantie; Patrick Dary; Jean-Marc Ferradou; Olivier Fondard; Jean Philippe Labarre; Jacques Mansourati; François Picard; Jean-Etienne Ricci; Muriel Salvat; Lamia Tartière; Jean-Bernard Ruidavets; Vanina Bongard; Cécile Delval; Guila Lancman; Hélène Pasche; Juan Fernando Ramirez-Gil; Atul Pathak; OSICAT Investigators. European Journal of Heart Failure. 2020.
Original source - Benefits and Challenges of Remote Patient Monitoring as Perceived by Health Care Practitioners: A Systematic Review
Luiza Palmieri Serrano; Karla C Maita; Francisco R Avila; Ricardo A Torres-Guzman; John P Garcia; Abdullah S Eldaly; Clifton R Haider; Christopher L Felton; Margaret R Paulson; Michael J Maniaci; Antonio J Forte. The Permanente Journal. 2023.
Original source - Using Virtual Models of Care for Chronic Disease Management in Outpatient Services: A Systematic Review of Quality of Care Outcomes
Maryam Sina; Rebecca Mitchell; Ramya Walsan; Robyn Clay Williams; Alex Cardenas; Michelle Moscova; Elizabeth Manias; Natalie Taylor; Virginia Mumford; Bradley Christian; Reema Harrison. Telemedicine and e-Health. 2025.
Original source - Effect of virtual care in type 2 diabetes management – a systematic umbrella review of systematic reviews and meta-analysis
Sumathy Ravi; Gideon Meyerowitz-Katz; Cassia Yung; Julie Ayre; Kirsten McCaffery; Glen Maberly; Carissa Bonner. BMC Health Services Research. 2025.
Original source - Effectiveness of remote home monitoring for patients with Chronic Obstructive Pulmonary Disease (COPD): systematic review
Fernanda Inagaki Nagase; Tania Stafinski; Melita Avdagovska; Michael K. Stickland; Evelyn Melita Etruw; Devidas Menon. BMC Health Services Research. 2022.
Original source - Uses of Virtual Care in Primary Care: Scoping Review
Payal Agarwal; Glenn George Fletcher; Karishini Ramamoorthi; Xiaomei Yao; Onil Bhattacharyya. Journal of Medical Internet Research. 2025.
Original source - Effectiveness of telehealth versus in-person care during the COVID-19 pandemic: a systematic review
Elham Hatef; Renee F Wilson; Allen Zhang; Susan M Hannum; Hadi Kharrazi; Stacey A Davis; Iman Foroughmand; Jonathan P Weiner; Karen A Robinson. npj Digital Medicine. 2024.
Original source - Telephone versus video consultations: A systematic review of comparative effectiveness studies and guidance for choosing the most appropriate modality
Liam J Caffery; Soraia De Camargo Catapan; Monica L Taylor; Jaimon T Kelly; Helen M Haydon; Anthony C Smith; Centaine L Snoswell. Journal of Telemedicine and Telecare. 2025.
Original source - Virtual Care Among Adults Facing Language Barriers: A Systematic Review and Meta-Analysis
Erica Wennberg; Zuhal Mohmand; David D'Arienzo; Safa Majeed Grant; Elizabeth Uleryk; Manav V Vyas; Susitha Wanigaratne; Astrid Guttmann. JAMA Network Open. 2025.
Original source - Potential Harms Resulting From Patient-Clinician Real-Time Clinical Encounters Using Video-Based Telehealth: A Rapid Evidence Review
Michael Rosen; C. Matthew Stewart; Hadi Kharrazi; Ritu Sharma; Montrell Vass; Allen Zhang; Eric B. Bass. Agency for Healthcare Research and Quality. 2023.
Original source